Table 2 Lung cancer cases morphologically confirmed
From: NSCLC molecular testing in Central and Eastern European countries
Country (number of responses) | Proportion of cases, % |
|---|---|
Bulgaria | 75* |
Croatia | 100* |
Czech Republic | 85† |
Israel | 100* |
Slovakia | 83* |
Slovenia | 92* |